# vTv Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:0cff2587-7b83-4ede-a478-e489b07162b7 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/vtv-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:47.349247+00:00 | | Last reviewed | 2026-10-17T04:46:47.349247+00:00 | ## Identity - Legal name: vTv Therapeutics Inc. - Display name: vTv Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T06:11:28.623394+00:00 | | Completeness | 0.409 | | Record Quality | 0.834 | | Directors | 7 | | Committees | 5 | | Governance events | 13 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Anne M. Phillips: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:5 - Fahed Al Marzooqi: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:6 - Paul Sekhri: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:7 - Raymond Cheong: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:8 - Richard S. Nelson: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:9 - Srinivas Akkaraju, M.D., Ph.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:10 - Daniel K. Spiegelman: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (chair); Nominating and Governance (member). claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_record:13 ## Committees - Audit (audit). Chair: Daniel K. Spiegelman. Members: Daniel K. Spiegelman (chair, current); Anne M. Phillips (member, current). committee_id=alpha:committee:vtv-therapeutics-inc:audit - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Anne M. Phillips (member, current). committee_id=alpha:committee:vtv-therapeutics-inc:audit-compensation-chair - Compensation (compensation). Chair: Anne M. Phillips. Members: Anne M. Phillips (chair, current); Fahed Al Marzooqi (member, current); Raymond Cheong (member, current). committee_id=alpha:committee:vtv-therapeutics-inc:compensation - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Raymond Cheong (member, current). committee_id=alpha:committee:vtv-therapeutics-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Raymond Cheong. Members: Raymond Cheong (chair, current); Daniel K. Spiegelman (member, current). committee_id=alpha:committee:vtv-therapeutics-inc:nominating-and-governance ## Executive leadership - Michael Tung: Executive Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:11 - Paul Sekhri: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:12 ## Governance events - CFO_CHANGED: Michael Tung executive of vTv Therapeutics Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:axhw0idbf4t4 - CEO_CHANGED: Paul Sekhri executive of vTv Therapeutics Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1063w6613d6y0o - DIRECTOR_APPOINTED: Anne M. Phillips seat on vTv Therapeutics Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1i604dy1rsyqgc - DIRECTOR_APPOINTED: Raymond Cheong seat on vTv Therapeutics Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1jmq04jab3af5 - DIRECTOR_APPOINTED: Srinivas Akkaraju, M.D., Ph.D. seat on vTv Therapeutics Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:mcvrku105qifc - COMMITTEE_CREATED: Audit; Compensation · Chair committee of vTv Therapeutics Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1s5soj01sn32c8 - COMMITTEE_MEMBER_ADDED: Anne M. Phillips member of Audit; Compensation · Chair, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:zdms8vctrv8p - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of vTv Therapeutics Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1et2um91l4jrtx - COMMITTEE_MEMBER_ADDED: Raymond Cheong member of Compensation; Nominating and Governance · Chair, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:9iq3ue6lek4e - DIRECTOR_APPOINTED: Fahed Al Marzooqi seat on vTv Therapeutics Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:15uw9w7cjhhnd - DIRECTOR_APPOINTED: Paul Sekhri seat on vTv Therapeutics Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1j1ka4c1im2rzo - COMMITTEE_MEMBER_ADDED: Fahed Al Marzooqi member of Compensation, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:p9w4427sfpyg - DIRECTOR_APPOINTED: Richard S. Nelson seat on vTv Therapeutics Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1ok3b2k1md0hx4 ## Scoped resources - `alpha://company/vtv-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record - `alpha://company/vtv-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=identity - `alpha://company/vtv-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/vtv-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=board - `alpha://company/vtv-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=committees - `alpha://company/vtv-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=leadership - `alpha://company/vtv-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=ownership - `alpha://company/vtv-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=financials - `alpha://company/vtv-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/vtv-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=compensation - `alpha://company/vtv-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=governance - `alpha://company/vtv-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/vtv-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=audit - `alpha://company/vtv-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=legal - `alpha://company/vtv-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=risk - `alpha://company/vtv-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=cyber - `alpha://company/vtv-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/vtv-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=agents - `alpha://company/vtv-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/vtv-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=events - `alpha://company/vtv-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=relationships - `alpha://company/vtv-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=assessments - `alpha://company/vtv-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:daniel-k-spiegelman","name":"Daniel K. Spiegelman"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:anne-m-phillips","name":"Anne M. Phillips"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:anne-m-phillips","name":"Anne M. Phillips"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:fahed-al-marzooqi","name":"Fahed Al Marzooqi"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:raymond-cheong","name":"Raymond Cheong"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:raymond-cheong","name":"Raymond Cheong"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:daniel-k-spiegelman","name":"Daniel K. Spiegelman"},"source_id":"board_seats"}` ## Leadership - Anne M. Phillips: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:5. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60. - Fahed Al Marzooqi: Director, Compensation. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:6. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60. - Paul Sekhri: Director. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60. - Raymond Cheong: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60. - Richard S. Nelson: Director. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60. - Srinivas Akkaraju, M.D., Ph.D.: Director. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60. - Michael Tung: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:11. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:91f8e4352a443beacde67ed1280e0d88aee46f3a73d11414ab14ab4825445006. - Paul Sekhri: President and Chief Executive Officer. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:leadership_role:12. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:de042f47f2ca11c9ac424d29578ac4f11fcaa8f24a3485d7efb0d4d56a5c5fba. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Daniel K. Spiegelman; Members Daniel K. Spiegelman (Chair); Anne M. Phillips. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. - Compensation: Chair Anne M. Phillips; Members Anne M. Phillips (Chair); Fahed Al Marzooqi; Raymond Cheong. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. - Nominating and Governance: Chair Raymond Cheong; Members Raymond Cheong (Chair); Daniel K. Spiegelman. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - vTv Therapeutics Inc.. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174f87cef0958bee42736b567c1661335a299edd957b0546ef084696a9b6490c. ## Entity Status - Public listing published. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174f87cef0958bee42736b567c1661335a299edd957b0546ef084696a9b6490c. ## Published Fact - US. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174f87cef0958bee42736b567c1661335a299edd957b0546ef084696a9b6490c. ## Committee Appointment - Daniel K. Spiegelman: chair, Audit. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. - Anne M. Phillips: member, Audit. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. - Anne M. Phillips: chair, Compensation. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. - Fahed Al Marzooqi: member, Compensation. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. - Raymond Cheong: member, Compensation. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. - Raymond Cheong: chair, Nominating and Governance. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. - Daniel K. Spiegelman: member, Nominating and Governance. Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b. ## Security Listing - VTVT (NASDAQ). Claim: alpha:claim:company:0cff2587-7b83-4ede-a478-e489b07162b7:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:174f87cef0958bee42736b567c1661335a299edd957b0546ef084696a9b6490c. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:174f87cef0958bee42736b567c1661335a299edd957b0546ef084696a9b6490c: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/vtv-therapeutics-inc). - alpha:projection-evidence:document:8d6d9856845d92614f0f75cba4eb3cb2046d9a40becb8c77838cbd90fe03be60: [vTv Therapeutics Inc. DEF 14A 2025-04-25](https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm). - alpha:projection-evidence:document:91f8e4352a443beacde67ed1280e0d88aee46f3a73d11414ab14ab4825445006: [VTVT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1641489/000164148926000015/vtvt-20260428.htm). - alpha:projection-evidence:document:de042f47f2ca11c9ac424d29578ac4f11fcaa8f24a3485d7efb0d4d56a5c5fba: [VTVT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1641489/000164148926000015/vtvt-20260428.htm). - alpha:projection-evidence:26d6d939efc5cbc260a4f18466e0a23492ee99e21a5c37da9713c6d743fc675b: [Audit](https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/vtv-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/vtv-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/vtv-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/vtv-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T06:11:28.40178+00:00; recorded 2026-10-17T06:11:28.40178+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.